Curagen (CRGN) Inactive 10-K2008 FY Annual report

Filed: 10 Mar 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: Absent, AICPA, alopecia, andADC, antidilutive, AU, borrowing, cient, confidence, customary, cutoff, dacarbazine, Denominator, depositor, depressed, diarrhea, evidenced, expiry, exploratory, faith, FDIC, forecast, forty, GAAP, Genentech, hierarchy, ImmunoGen, intracellular, involuntary, irrevocable, iSBTc, left, letter, linked, maytansine, monomethylaurastatin, Nineteen, nonconvertible, nongovernmental, Numerator, PFS, poorest, rash, regular, resume, resuming, resumption, SAS, send, shrinkage, Simon, suffi, temozolamide, trastuzumab, TSA, turmoil, unconfirmed, unobservable, weekly, widening

Removed: AACR, accruing, AG, armstrong, arrest, Asia, automatically, awarded, bortezomib, calculating, cancellation, carcinoma, collaborating, computing, conserve, convert, CTA, curtail, cycle, david, death, default, detailed, differentiation, dilute, disorder, downturn, durable, efficiently, Elizabeth, epithelial, expand, facilitate, feet, fibroblast, firm, forma, frank, fundamental, Gloucester, growth, hematological, Ib, impaired, incurrence, indenture, induce, inflammation, inflammatory, inhibit, initiate, Institute, IPO, lapsing, leukemia, leveraging, library, loan, lymphoma, mechanistic, Merck, metabolic, molecular, monotherapy, myeloma, NCI, North, notable, occurring, ovarian, overcome, parallel, Pharma, pro, programmed, progression, promote, radiotherapy, ready, receivable, recombinant, registration, regression, renal, replaced, reportable, represent, resistance, resistant, restated, restrictive, sarcoma, secondary, secured, segment, select, sensitize, sharing, simultaneously, slightly, smaller, square, stemming, striving, subscription, subset, suggested, supplemented, synergistic, tissue, toxicity, underwriting, unique, USD, Velcade, vomiting, vulnerable, weight, Whayland, wurzer, xenograft

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CRGN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statements No. 333-56829, No. 333-89465, No. 333-108119 and No. 333-144440 on Form S-8, and Registration Statements No. 333-113930 on Form S-3 of our report dated March 9, 2009 which expresses an unqualified opinion relating to the consolidated financial statements of CuraGen Corporation and the effectiveness of CuraGen Corporation’s internal control over financial reporting appearing in this Annual Report on Form 10-K of CuraGen Corporation for the year ended December 31, 2008.

/s/ DELOITTE & TOUCHE LLP

Hartford, Connecticut

March 9, 2009